A.R.T. Advisors, LLC - NAVIDEA BIOPHARMACEUTICALS I ownership

NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVBXXXX and the CUSIP is 63937X103. A total of 78 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q4 2015. The put-call ratio across all filers is 97.39 and the average weighting 0.8%.

Quarter-by-quarter ownership
A.R.T. Advisors, LLC ownership history of NAVIDEA BIOPHARMACEUTICALS I
ValueSharesWeighting
Q4 2016$32,000
-69.2%
51,700
-73.9%
0.00%
-60.0%
Q2 2016$104,000
+67.7%
197,812
+319.3%
0.01%
+66.7%
Q4 2015$62,00047,1720.00%
Other shareholders
NAVIDEA BIOPHARMACEUTICALS I shareholders Q4 2015
NameSharesValueWeighting ↓
Sowell Financial Services LLC 1,507,457$593,0000.17%
Harel Insurance Investments & Financial Services Ltd. 780,000$398,0000.03%
Spark Investment Management LLC 353,400$180,0000.01%
LifePlan Financial Group, Inc 28,810$15,0000.01%
Greenwich Wealth Management LLC 60,066$31,0000.01%
SHINE INVESTMENT ADVISORY SERVICES INC 19,608$10,0000.01%
Virtu KCG Holdings LLC 336,414$172,0000.01%
LYNCH & ASSOCIATES/IN 18,000$9,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 649,880$331,0000.00%
JACOBS LEVY EQUITY MANAGEMENT, INC 377,875$193,0000.00%
View complete list of NAVIDEA BIOPHARMACEUTICALS I shareholders